Department of Endocrinology & Metabolism, Hospital Universitario Ramón y Cajal, Madrid, Spain.
Instituto de Investigación Biomédica Ramón y Cajal (IRYCIS), Madrid, Spain.
Endocrine. 2021 Apr;72(1):40-48. doi: 10.1007/s12020-020-02544-6. Epub 2020 Nov 21.
To review the literature assessing the diagnostic performance of urinary steroid profiling (USP) by high-performance liquid chromatography (LC-MS) or gas chromatography (GC) coupled to mass spectrometry (MS) in the evaluation of adrenal lesions, both in terms of functionality and malignancy.
The evaluation of adrenal incidentalomas (AI) aims to rule out malignancy and hormone excess. Current diagnostic protocols have several limitations and include time consuming and relatively complicated multi-step processes in most cases. On the contrary, USP by LC-MS/MS or LC-GC/MS offer an easy, comprehensive and non-invasive assessment of adrenal steroid secretion. USP complements current workups used in the evaluation of AIs by improving our ability to identify malignancy and/or autonomous hormone secretion.
Urine steroid profiling by LC-MS/MS and GC-MS allows a thorough, non-invasive, assessment of adrenal steroidogenesis as a whole which complement the current evaluation of AIs, and holds a promising role in the diagnosis of autonomous cortisol secretion, primary aldosteronism, and adrenal malignancy.
通过高效液相色谱(LC-MS)或气相色谱(GC)与质谱(MS)联用评估尿甾体谱(USP)在评估肾上腺病变中的诊断性能,包括功能和恶性肿瘤方面。
评估意外发现的肾上腺肿瘤(AI)旨在排除恶性肿瘤和激素过多。目前的诊断方案存在一些局限性,包括在大多数情况下耗时且相对复杂的多步骤过程。相比之下,LC-MS/MS 或 LC-GC/MS 的 USP 提供了一种简单、全面且非侵入性的肾上腺类固醇分泌评估方法。USP 通过提高我们识别恶性肿瘤和/或自主激素分泌的能力,补充了当前用于评估 AI 的工作流程。
LC-MS/MS 和 GC-MS 的尿甾体谱分析可全面、非侵入性地评估肾上腺甾体生成,补充了当前对 AI 的评估,并在诊断自主皮质醇分泌、原发性醛固酮增多症和肾上腺恶性肿瘤方面具有广阔的应用前景。